Jong Joseph Kim Inovio Pharmaceuticals, Inc. (INO) insider trading activity

Jong Joseph Kim is Chief Executive Officer of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.42 Million shares of INO, which is worth approximately $5.79 Million. The most recent transaction as insider was on Mar 11, 2022, when has been sold 39,698 shares (Common Stock) at a price of $3.22 per share, resulting in proceeds of $127,828. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.42M

0% 3M change

0% 12M change

Total Value Held $5.79 Million

Jong Joseph Kim Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 11 2022	SELL Payment of exercise price or tax liability	$127,828 $3.22 p/Share	39,698 Reduced 2.71%	1,422,627 Common Stock
Mar 11 2022	BUY Exercise of conversion of derivative security	-	139,387 Added 8.7%	1,462,325 Common Stock
Mar 08 2022	SELL Payment of exercise price or tax liability	$59,143 $3.26 p/Share	18,142 Reduced 1.35%	1,322,938 Common Stock
Mar 08 2022	BUY Exercise of conversion of derivative security	-	63,700 Added 4.53%	1,341,080 Common Stock
Feb 26 2022	SELL Payment of exercise price or tax liability	$64,545 $3.22 p/Share	20,045 Reduced 1.54%	1,277,380 Common Stock
Feb 26 2022	BUY Exercise of conversion of derivative security	-	68,767 Added 5.03%	1,297,425 Common Stock
Mar 11 2021	SELL Payment of exercise price or tax liability	$787,941 $10.57 p/Share	74,545 Reduced 5.72%	1,228,658 Common Stock
Mar 11 2021	BUY Exercise of conversion of derivative security	-	139,387 Added 9.66%	1,303,203 Common Stock
Mar 08 2021	SELL Payment of exercise price or tax liability	$303,537 $8.91 p/Share	34,067 Reduced 2.84%	1,163,816 Common Stock
Mar 08 2021	BUY Exercise of conversion of derivative security	-	63,700 Added 5.05%	1,197,883 Common Stock
Mar 05 2021	SELL Payment of exercise price or tax liability	$590,274 $9.19 p/Share	64,230 Reduced 5.36%	1,134,183 Common Stock
Mar 05 2021	BUY Exercise of conversion of derivative security	-	120,100 Added 9.11%	1,198,413 Common Stock
Feb 03 2021	SELL Open market or private sale	$890,000 $14.24 p/Share	62,500 Reduced 5.48%	1,078,313 Common Stock
Feb 03 2021	BUY Exercise of conversion of derivative security	$285,000 $4.56 p/Share	62,500 Added 5.19%	1,140,813 Common Stock
Feb 01 2021	SELL Open market or private sale	$1,500,000 $15.0 p/Share	100,000 Reduced 8.49%	1,078,313 Common Stock
Dec 29 2020	SELL Bona fide gift	-	10,000 Reduced 0.84%	1,178,313 Common Stock

JJK

Jong Joseph Kim

Chief Executive Officer

Plymouth Meeting, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Value

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

Operation

Value

Type

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO

Account